Positives for GE HealthCare Technologies Inc (GEHC) as stock gains in recent trading

GE HealthCare Technologies Inc (NASDAQ: GEHC) is 5.20% higher on its value in year-to-date trading and has touched a low of $62.35 and a high of $87.83 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The GEHC stock was last observed hovering at around $82.06 in the last trading session, with the day’s loss setting it -0.72%.

Currently trading at $81.34, the stock is 8.24% and 9.51% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.76 million and changing -0.88% at the moment leaves the stock 10.38% off its SMA200. GEHC registered 15.92% gain for a year compared to 6-month gain of 12.50%. The firm has a 50-day simple moving average (SMA 50) of $2.29 and a 200-day simple moving average (SMA200) of $12.73.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

The stock witnessed a 6.79% loss in the last 1 month and extending the period to 3 months gives it a 16.22%, and is 10.05% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.51% over the week and 2.50% over the month.

GE HealthCare Technologies Inc (GEHC) has around Jan 12 2024 employees, a market worth around $37.04B and $19.55B in sales. Current P/E ratio is 26.89 and Fwd P/E is 16.97. Profit margin for the company is 7.08%. Distance from 52-week low is 30.46% and -7.39% from its 52-week high. The company has generated returns on investments over the last 12 months (8.72%).

GE HealthCare Technologies Inc quarterly earnings per share for the current quarter are estimated at $0.91 with sales reaching $4.82B over the same period.The EPS is expected to grow by 8.67% this year, but quarterly earnings will post 3.50% year-over-year. Quarterly sales are estimated to grow 2.30% in year-over-year returns.

GE HealthCare Technologies Inc (GEHC) Top Institutional Holders

1,459 institutions hold shares in GE HealthCare Technologies Inc (GEHC), with institutional investors hold 83.88% of the company’s shares. The shares outstanding are 455.34M, and float is at 392.55M with Short Float at 3.99%. Institutions hold 83.82% of the Float.

The top institutional shareholder in the company is General Electric Company with over 61.58 million shares valued at $5.0 billion. The investor’s holdings represent 13.54% of the GEHC Shares outstanding. As of Jun 29, 2023, the second largest holder is Capital Research Global Investors with 49.57 million shares valued at $4.03 billion to account for 10.90% of the shares outstanding. The other top investors are Vanguard Group Inc which holds 38.84 million shares representing 8.54% and valued at over $3.16 billion, while Blackrock Inc. holds 6.32% of the shares totaling 28.74 million with a market value of $2.33 billion.

GE HealthCare Technologies Inc (GEHC) Insider Activity

A total of 1 insider transactions have happened at GE HealthCare Technologies Inc (GEHC) in the last six months, with sales accounting for 1 and purchases happening 0 times. The most recent transaction is an insider sale by O’Neill Kevin Michael ,the company’sCEO, PDx. SEC filings show that O’Neill Kevin Michael sold 15,609 shares of the company’s common stock on Jul 31 at a price of $77.32 per share for a total of $1.21 million. Following the sale, the insider now owns 24025.0 shares.

GE HealthCare Technologies Inc disclosed in a document filed with the SEC on Jun 08 that Rott Roland (CEO, Ultrasound) sold a total of 2,473 shares of the company’s common stock. The trade occurred on Jun 08 and was made at $77.37 per share for $0.19 million. Following the transaction, the insider now directly holds 22335.0 shares of the GEHC stock.

Still, SEC filings show that on Mar 14, Makela Jan (CEO, Imaging) disposed off 70,629 shares at an average price of $77.69 for $5.49 million. The insider now directly holds 63,796 shares of GE HealthCare Technologies Inc (GEHC).